Month: March 2020

A new investment in Sachsen-Anhalt is announced to build a pilot facility to support healthcare related research & development and the manufacturing of proteins for diagnostic use.

Posted by

Con­cep­tu­al image of the new R&D facil­i­ty   Den­ka Com­pa­ny Lim­it­ed (head­quar­ters: Chuo-ku, Tokyo; pres­i­dent: Man­abu Yamamo­to; here­inafter, “Den­ka”) announces that Icon Genet­ics GmbH (here­inafter, ”Icon Genet­ics”), a ful­ly owned sub­sidiary of Den­ka, con­clud­ed a land pur­chase agree­ment with the city of Halle, Sach­sen-Anhalt in Ger­many on March 11, 2020. The land will be used… Read more »